Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein

Parkinson's disease is a neurodegenerative movement disorder caused by the loss of dopaminergic neurons from substantia nigra. It is characterized by the accumulation of aggregated α-synuclein as the major component of the Lewy bodies. Additional common features of this disease are the mitochon...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2018
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10447431_v88_n_p107_Martinez
http://hdl.handle.net/20.500.12110/paper_10447431_v88_n_p107_Martinez
Aporte de:
id paper:paper_10447431_v88_n_p107_Martinez
record_format dspace
spelling paper:paper_10447431_v88_n_p107_Martinez2023-06-08T16:01:07Z Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein alpha-synuclein autophagy mitochondria mitochondrial dynamics mitophagy Parkinson's Disease alpha synuclein dynamin related protein 1 hybrid protein mitochondrial protein optic atrophy 1 protein reactive oxygen metabolite unclassified drug alpha synuclein DNM1L protein, human guanosine triphosphatase microtubule associated protein mitochondrial protein OPA1 protein, human SNCA protein, human Article autophagy cell death cell protection cell survival cell viability controlled study cytotoxicity disorders of mitochondrial functions dopaminergic nerve cell gene overexpression human human cell in vitro study mitochondrial dynamics mitochondrial fragmentation mitophagy Parkinson disease priority journal SH-SY5Y cell line wild type autophagy dopaminergic nerve cell genetics metabolism mitochondrion physiology substantia nigra tumor cell line alpha-Synuclein Autophagy Cell Line, Tumor Dopaminergic Neurons GTP Phosphohydrolases Humans Microtubule-Associated Proteins Mitochondria Mitochondrial Degradation Mitochondrial Dynamics Mitochondrial Proteins Parkinson Disease Substantia Nigra Parkinson's disease is a neurodegenerative movement disorder caused by the loss of dopaminergic neurons from substantia nigra. It is characterized by the accumulation of aggregated α-synuclein as the major component of the Lewy bodies. Additional common features of this disease are the mitochondrial dysfunction and the activation/inhibition of autophagy both events associated to the intracellular accumulation of α-synuclein. The mechanism by which these events contribute to neural degeneration remains unknown. In the present work we investigated the effect of α-synuclein on mitochondrial dynamics and autophagy/mitophagy in SH-SY5Y cells, an in vitro model of Parkinson disease. We demonstrated that overexpression of wild type α-synuclein causes moderated toxicity, ROS generation and mitochondrial dysfunction. In addition, α-synuclein induces the mitochondrial fragmentation on a Drp-1-dependent fashion. Overexpression of the fusion protein Opa-1 prevented both mitochondrial fragmentation and cytotoxicity. On the other hand, cells expressing α-synuclein showed activated autophagy and particularly mitophagy. Employing a genetic strategy we demonstrated that autophagy is triggered in order to protect cells from α-synuclein-induced cell death. Our results clarify the role of Opa-1 and Drp-1 in mitochondrial dynamics and cell survival, a controversial α-synuclein research issue. The findings presented point to the relevance of mitochondrial homeostasis and autophagy in the pathogenesis of PD. Better understanding of the molecular interaction between these processes could give rise to novel therapeutic methods for PD prevention and amelioration. © 2018 Elsevier Inc. 2018 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10447431_v88_n_p107_Martinez http://hdl.handle.net/20.500.12110/paper_10447431_v88_n_p107_Martinez
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic alpha-synuclein
autophagy
mitochondria
mitochondrial dynamics
mitophagy
Parkinson's Disease
alpha synuclein
dynamin related protein 1
hybrid protein
mitochondrial protein
optic atrophy 1 protein
reactive oxygen metabolite
unclassified drug
alpha synuclein
DNM1L protein, human
guanosine triphosphatase
microtubule associated protein
mitochondrial protein
OPA1 protein, human
SNCA protein, human
Article
autophagy
cell death
cell protection
cell survival
cell viability
controlled study
cytotoxicity
disorders of mitochondrial functions
dopaminergic nerve cell
gene overexpression
human
human cell
in vitro study
mitochondrial dynamics
mitochondrial fragmentation
mitophagy
Parkinson disease
priority journal
SH-SY5Y cell line
wild type
autophagy
dopaminergic nerve cell
genetics
metabolism
mitochondrion
physiology
substantia nigra
tumor cell line
alpha-Synuclein
Autophagy
Cell Line, Tumor
Dopaminergic Neurons
GTP Phosphohydrolases
Humans
Microtubule-Associated Proteins
Mitochondria
Mitochondrial Degradation
Mitochondrial Dynamics
Mitochondrial Proteins
Parkinson Disease
Substantia Nigra
spellingShingle alpha-synuclein
autophagy
mitochondria
mitochondrial dynamics
mitophagy
Parkinson's Disease
alpha synuclein
dynamin related protein 1
hybrid protein
mitochondrial protein
optic atrophy 1 protein
reactive oxygen metabolite
unclassified drug
alpha synuclein
DNM1L protein, human
guanosine triphosphatase
microtubule associated protein
mitochondrial protein
OPA1 protein, human
SNCA protein, human
Article
autophagy
cell death
cell protection
cell survival
cell viability
controlled study
cytotoxicity
disorders of mitochondrial functions
dopaminergic nerve cell
gene overexpression
human
human cell
in vitro study
mitochondrial dynamics
mitochondrial fragmentation
mitophagy
Parkinson disease
priority journal
SH-SY5Y cell line
wild type
autophagy
dopaminergic nerve cell
genetics
metabolism
mitochondrion
physiology
substantia nigra
tumor cell line
alpha-Synuclein
Autophagy
Cell Line, Tumor
Dopaminergic Neurons
GTP Phosphohydrolases
Humans
Microtubule-Associated Proteins
Mitochondria
Mitochondrial Degradation
Mitochondrial Dynamics
Mitochondrial Proteins
Parkinson Disease
Substantia Nigra
Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
topic_facet alpha-synuclein
autophagy
mitochondria
mitochondrial dynamics
mitophagy
Parkinson's Disease
alpha synuclein
dynamin related protein 1
hybrid protein
mitochondrial protein
optic atrophy 1 protein
reactive oxygen metabolite
unclassified drug
alpha synuclein
DNM1L protein, human
guanosine triphosphatase
microtubule associated protein
mitochondrial protein
OPA1 protein, human
SNCA protein, human
Article
autophagy
cell death
cell protection
cell survival
cell viability
controlled study
cytotoxicity
disorders of mitochondrial functions
dopaminergic nerve cell
gene overexpression
human
human cell
in vitro study
mitochondrial dynamics
mitochondrial fragmentation
mitophagy
Parkinson disease
priority journal
SH-SY5Y cell line
wild type
autophagy
dopaminergic nerve cell
genetics
metabolism
mitochondrion
physiology
substantia nigra
tumor cell line
alpha-Synuclein
Autophagy
Cell Line, Tumor
Dopaminergic Neurons
GTP Phosphohydrolases
Humans
Microtubule-Associated Proteins
Mitochondria
Mitochondrial Degradation
Mitochondrial Dynamics
Mitochondrial Proteins
Parkinson Disease
Substantia Nigra
description Parkinson's disease is a neurodegenerative movement disorder caused by the loss of dopaminergic neurons from substantia nigra. It is characterized by the accumulation of aggregated α-synuclein as the major component of the Lewy bodies. Additional common features of this disease are the mitochondrial dysfunction and the activation/inhibition of autophagy both events associated to the intracellular accumulation of α-synuclein. The mechanism by which these events contribute to neural degeneration remains unknown. In the present work we investigated the effect of α-synuclein on mitochondrial dynamics and autophagy/mitophagy in SH-SY5Y cells, an in vitro model of Parkinson disease. We demonstrated that overexpression of wild type α-synuclein causes moderated toxicity, ROS generation and mitochondrial dysfunction. In addition, α-synuclein induces the mitochondrial fragmentation on a Drp-1-dependent fashion. Overexpression of the fusion protein Opa-1 prevented both mitochondrial fragmentation and cytotoxicity. On the other hand, cells expressing α-synuclein showed activated autophagy and particularly mitophagy. Employing a genetic strategy we demonstrated that autophagy is triggered in order to protect cells from α-synuclein-induced cell death. Our results clarify the role of Opa-1 and Drp-1 in mitochondrial dynamics and cell survival, a controversial α-synuclein research issue. The findings presented point to the relevance of mitochondrial homeostasis and autophagy in the pathogenesis of PD. Better understanding of the molecular interaction between these processes could give rise to novel therapeutic methods for PD prevention and amelioration. © 2018 Elsevier Inc.
title Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
title_short Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
title_full Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
title_fullStr Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
title_full_unstemmed Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein
title_sort drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic sh-sy5y cells overexpressing alpha-synuclein
publishDate 2018
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10447431_v88_n_p107_Martinez
http://hdl.handle.net/20.500.12110/paper_10447431_v88_n_p107_Martinez
_version_ 1768544968634269696